Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachlorideShow More
The publisher has not yet granted permission to display this abstract.
Keywords: Metformin/empagliflozin / AMPKα / NF-κB / p38 MAPK / ERK1/2 / Liver fibrosis
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Life Sciences" .